Except for the pre-congress courses, these sessions are included with full-congress registration or register for free via the “Open-Access Sessions” on the WCN Portal to attend a particular session.
The ISN World Congress of Nephrology, Kuala Lumpur, Malaysia, 24/02/2022-27/02/2022, is accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 18 European CME credits (ECMEC®s).
By Siah Kim (Australia), Member, Young Nephrologists Committee
Drum Roll, Please! ISN Young Nephrologists On-Stage at WCN'22
WCN'22 is just around the corner, and the Young Nephrologists Committee is thrilled to invite all young nephrologists (and the young at heart!) to a program packed with exciting events planned with you in mind.
This is the moment to cast off the gloominess of the past two years and get inspired by stories from young nephrologists who have maintained their commitment to education, training, and patient care, despite being in the thick of the pandemic.
Deadline Extension: More Time to Get Involved in the ISN Frontiers Meeting in Bergamo, Italy - Submit Your Abstract Until March 2
The new deadline for abstract submissions and travel grant applications is March 2, 2022. Submit your abstract here.
Take advantage of a rare opportunity to present your research work to clinicians, scientists, academics, and general practitioners from around the world at the ISN Frontiers Meeting‘Complement-related kidney diseases: classification, genetics, and treatment.'
This meeting is accredited by the European Accreditation Council for Continuing Medical Education - full details here.
Accepted abstracts will be presented as posters and published in Kidney International Reports. Some abstracts will be selected for oral presentations at the meeting.
Announcing Three New ISN-TTS Sister Transplant Centers Partnerships and One Graduating Pair
Submit a Proposal to the ISN Clinical Research Program
Could your region benefit from support for research and education initiatives that help detect and manage non-communicable chronic diseases such as CKD, AKI, hypertension, diabetes, and cardiovascular disease? The ISN Clinical Research Program helps implement such projects.
Proposals for the ISN Clinical Research Program should be submitted to an ISN Regional Coordinator for review before April 1, 2022.
Once approved, proposals can be submitted hereuntil May 1, 2022.
Share the photo on social media using the hashtag #ShowYourKidneys.
Find additional inspiration for your social media post here.
World Kidney Day social media platforms will share all photos tagged @worldkidneyday.
The ISN encourages all to participate in this initiative and share it with their colleagues, patients, and families. Discover and use all WKD resources here.
Promoting Global Kidney Health at the WHO 150th Session of the Executive Board
The ISN submitted three statements supporting global kidney health, as a co- and sole-signatory, at the 150th session of the World Health Organization’s Executive Board, held virtually, 24-29 January 2022.
Newly Revised ISN-ACT Clinical Trials Toolkit Available to Explore Now
Explore the second revised edition of the ISN-ACT Clinical Trials Toolkit here.
The online Clinical Trials Toolkit was first launched in 2020 to provide the kidney community with a central and user-friendly resource for those wishing to participate in randomized research.
Watch a short introductory video on the toolkit here.
Listen to a podcast on the toolkit here (episode 7, part 2).
The toolkit is a hub for researchers, providing essential evidence to guide care for kidney disease patients. It assists anyone wishing to start a clinical trial or participate as a trial site, regardless of their level of experience.
Watch a webinar on the toolkit presented by David Wheeler, Brendan Smyth, Rasha Hussein, and Augusto Cesar Soares dos Santos Jr. here.
Thursday, March 10
World Kidney Day 2022: Bridge the Knowledge Gap to Better Kidney Care - Bringing Together the Community for Kidney Health
Session 1: 11 a.m. CET /
Session 2: 10 p.m. CET
Agnes Fogo, USA
SF Lui, Hong Kong
Verónica Martínez, Mexico
Manvir Victor, Malaysia
Ann Bonner, Australia
Beatrice Titilola Segun-Agboola, Nigeria
Paul Laffin, France
Robyn Langham, Australia (Session 1)
Kam Kalantar Zadeh, USA (Session 2)
The Changing Role of Glucocorticoids in the Treatment of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (AAV)
This editorial outlines the use of Glucocorticoids (GCs) to treat patients with antineutrophil cytoplasm antibody (ANCA)-associated vasculitis (AAV).
The authors discuss recent randomized control trials on AAV management that may limit GC exposure; uncontrolled studies that demonstrate the potential of using a regimen combining cyclophosphamide and rituximab, and present findings from the Prolonged REmission-MAINtenance therapy in systemic vasculitis (REMAIN) study. The authors propose considerations for future studies based on this analysis.
The Lupus Nephritis Management Renaissance
This review examines the overall strategy of managing Lupus Nephritis (LN) as new therapies come into use. It assesses the use of kidney biopsies, molecular technologies, and LN Biomarkers and considers how best to use these developments now and in the future.
GLP-1 Receptor Agonist Versus DPP4 Inhibitor and Kidney and Cardiovascular Outcomes in Clinical Practice in Type-2 Diabetes
A cohort study compares kidney and cardiovascular outcomes in individuals who started GLP1-RA or dipeptidyl peptidase-4 inhibitors (DPP4i) to help clarify whether glucagon-like peptide-1 receptor agonists (GLP1-RA) reduce detrimental kidney outcomes. The use of GLP1-RA was associated with a lower risk of kidney outcomes compared with DPP4i. Reductions in both kidney outcomes and MACE were similar in magnitude to those reported in large cardiovascular outcome trials.
Nephrology Workforce and Education in Conflict Zones
Using data collected initially to establish a conservative kidney management program in Northwestern Syria, the authors of this editorial examine the degree of nephrologist shortages in conflict zones and the effects of conflict on nephrology training.
They propose possible solutions to alleviate the consequences of a lack of appropriate training due to warfare, acknowledging that in areas of protracted conflict, nephrology training programs need the support of local volunteers and international humanitarian forces to be beneficial.